World Wires · Story 122091 · corroborated · 1 Quelle(n)

Molecular Mechanisms of Quizartinib Resistance in FLT3 Mutants

Quizartinib, a type II FLT3 inhibitor approved for FLT3-ITD-positive acute myeloid leukemia (AML), is frequently limited by acquired resistance, which aris

Im Desk öffnen

Berichterstattung

• Molecular Mechanisms of Quizartinib Resistance in FLT3 Mutants bioRxiv (new preprints) · Stufe C · Clear Net · 2026-11-10 00:00 UTC

Was diese Seite indexiert